Home/Pipeline/QVCAD for ABUS

QVCAD for ABUS

Breast Cancer Screening (Dense Breast Tissue)

ApprovedActive

Key Facts

Indication
Breast Cancer Screening (Dense Breast Tissue)
Phase
Approved
Status
Active
Company

About QView Medical

QView Medical is a pioneer in AI-driven diagnostics for breast cancer, with a team possessing a 20-year legacy in securing FDA Premarket Approvals (PMAs) for CAD systems. The company's flagship product, QVCAD, is the first FDA-approved CAD system for 3D Automated Breast Ultrasound (ABUS) screening, specifically targeting the significant challenge of detecting cancer in women with dense breast tissue where mammography is less effective. The company is currently commercial, with its technology live in clinical production at sites like Eve Wellness in San Francisco. QView operates at the intersection of AI, medical imaging, and regulatory expertise, aiming to establish a new standard of care in supplemental breast cancer screening.

View full company profile

Therapeutic Areas